维普期刊资源整合服务平台（V6.5）

27篇 您的检索式：作者名="LAGAS JS"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	Neuroimaging of autism 显示文摘	Verhoeven JS De Cock P Lagae L	2010	Neuroradiology2010，52，1：	1
2	Neuroimaging of autism显示文摘	Verhoeven JS De Cock P Lagae L	2010	Neuroradiology2010，52，11：	1
3	Neuroimaging of autism 显示文摘	Verhoeven JS De Cock P Lagae L	2010	Neuroradiology2010，52，1：	1
4	Multi- drug resistance protein 2 is an important determinant of paclitaxel pharmacokinetics显示文摘	Lagas JS Vlaming ML van Tellingen O	2006	Clin Cancer Res2006，12，201：	1
5	Liquid chromatography tandem mass spectrometric assay for diclofenac and three primary metabolites in mouse plasma显示文摘	Sparidans RW Lagas JS Schinkel AH	2008	J Chromatogr B2008，872，12：	1
6	Brain accumulation of dasatinib is restricted by P-glycoprotein (ABCB1) and breast cancer resistance protein (ABCG2) and can be enhanced by elacridar treatment 显示文摘	Lagas JS van Waterschoot RA van Tilburg VA	2009	Clin Cancer Res2009，15，：	1
7	Transport of diclofenac by breast cancer resistance protein (ABCG2) and stimulation of multidrug resistance protein 2 (ABCC2)-mediated drug transport by diclofenac and benzbro-marone 显示文摘	Lagas JS van der Kruijssen CM van de Wetering K	2009	Drug Metab Dispos2009，37，：	1
8	Multidrug resistance protein 2 is an important determinant of Paclitaxel Pharmacokinetics显示文摘	Lagas JS Vlaming ML van Tellingen O	2006	Clin Cancer Res2006，12，20：	1
9	Neuroimaging of autism显示文摘	Verhoeven JS De Cock P Lagae L	2010	Neuroradiology2010，52，1：	1
10	Breast canc- er resistance protein and P-glycoprotein limit sorafenib brain accu- mulation显示文摘	Lagas JS van Waterschoot RA Sparidans RW	2010	Mol Cancer Ther2010，9，2：	1
11	Brain accumulation of dasatinib is restricted by P-glycoprotein(ABCB1)and breast cancer resistance protein(ABCG2)and can be enhanced by elacridar treatment显示文摘	Lagas JS van Waterschoot RAB van Tilburg VACJ		0，，07：	1
12	Brain accumulation of sunitinib is restricted by P-glycoprotein ( ABCB1 ) and breast cancer resistance protein(ABCG2) and can be enhanced by oral elacridar and sunitinib coadministration 显示文摘	Tang SC Lagas JS Lankheet NA	2012	Int J Cancer2012，130，1：	1
13	Breast cancer resistance protein and P-glycoprotein limit sorafenib brain accumulation 显示文摘	Lagas JS van Waterschoot RA Sparidans RW	2010	Mol Cancer Ther2010，9，：	1
14	P-glycoprotein(P-gp/Abcb1),Abcc2,and Abcc3 determine the pharmacokinetics of etoposide显示文摘	Lagas JS Fan L Wagenaar E	2010	Clin Cancer Res2010，16，1：	1
15	Liquid chromatography-tandem mass spectrometric assay for sorafenib and sorafenib-glucuronide in mouse plasma and liver homogenate and identification of the glucuronide metabolite显示文摘	Sparidans RW Vlaming MLH Lagas JS		0，，：	1
16	Brain accumulation of sunitinib is restricted by P-glycoprotein(ABCB1)and breast cancer resistance protein(ABCG2)and can be enhanced by oral elacridar and sunitinib coadministration显示文摘	Tang SC Lagas JS Lankheet NAG		0，，01：	1
17	Neuroimaging of autism显示文摘	Verhoeven JS De Cock P Lagae L	2010	Neuroradiology2010，52，1：	1
18	Brain accumulation of dasatinib is restricted by P- glycoprotein (ABCB1) and breast cancer resistance protein (ABCG2) and can be enhanced by elacridar treatment 显示文摘	LAGAS JS van WATERSCHOOT RA van TILBURG VA et a/	2009	Clin Cancer Res2009，15，7：	1
19	Brain accumulation of sunitinib is restricted by P-glycoprotein (ABCB1) and breast cancer resistance protein (ABCG2) and can be enhanced by oral elacridar and sunitinib coadministration 显示文摘	Tang SC Lagas JS Lankheet NA	2012	Int J Cancer2012，130，1：	1
20	Absence of both cytochrome P450 3A and P-glycoprotein dramatically increases docetaxel oral bioavailability and risk of intestinal toxicity显示文摘	van Waterschoot RA Lagas JS Wagenaar E	2009	Cancer Res2009，69，23：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示